DEF: Azitra Seeks Shareholder Approval for Critical Capital Raise

Azitra, Inc. urges stockholders to approve a share issuance exceeding 19.99% to Alumni Capital LP, crucial for securing an additional $1.5 million in funding and avoiding severe operational risks.

Summary

• Azitra, Inc. is holding a Special Meeting of Stockholders on February 6, 2026, to vote on two proposals.
• The primary proposal (Proposal 1) seeks stockholder approval for the issuance of more than 19.99% of the company's common stock, comprised of shares underlying warrants, to Alumni Capital LP.
• This approval is required to comply with NYSE American Company Guide Sections 713(a) and 713(b) following a Securities Purchase Agreement dated November 24, 2025.
• The company has already received approximately $1.5 million in gross proceeds from the initial closing of the offering on November 25, 2025.
• Stockholder approval of Proposal 1 is a condition for the company to receive an additional approximately $1.5 million in gross proceeds if Alumni Capital exercises its warrants for cash in full, potentially bringing total gross proceeds to $3.0 million.
• The company's existing cash and cash equivalents are not sufficient to fund operating expenses and capital expenditure requirements through the next twelve months.
• Failure to obtain stockholder approval could materially adversely affect the company's ability to raise equity, delay or eliminate development efforts, negatively impact revenue, or lead to a reduction in operations or even bankruptcy.
• The second proposal (Proposal 2) is to approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are insufficient votes for Proposal 1.
• As of January 2, 2026, there were 10,740,697 shares of common stock outstanding and entitled to vote.
• A 1-for-6.66 reverse stock split was effected on August 20, 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the company's explicit disclosure of insufficient cash to fund operations for the next twelve months and the severe risks, including potential bankruptcy, if the critical capital raise is not fully realized. While the board recommends approval, the underlying financial situation is precarious.

Positives

• The company has already secured approximately $1.5 million in gross proceeds from the initial closing of the offering with Alumni Capital LP.
• Approval of Proposal 1 would enable the company to receive an additional approximately $1.5 million in gross proceeds from warrant exercises, providing critical capital.
• The transaction provides a reliable source of capital from an institutional investor at a relatively lower cost compared to other sources.
• Securing the additional capital would provide the company with more flexibility to pursue its business growth objectives.

Negatives

• The company's existing cash and cash equivalents are not sufficient to fund operating expenses and capital expenditure requirements through the next twelve months.
• Failure to approve Proposal 1 may materially adversely affect the company's future ability to raise equity.
• Without the additional capital, the company may have to delay, reduce, or eliminate significant portions of its development and other efforts, negatively impacting revenue opportunities.
• There is a risk of reducing marketing, ceasing operations entirely, or filing for bankruptcy if sufficient additional capital is not raised in the very near-term.
• The issuance of additional shares upon warrant exercise would result in greater dilution to existing stockholders and could lead to a decline in stock price or greater price volatility.
• The company will incur substantial additional costs and expenses if it has to hold repeated stockholder meetings due to a lack of approval for Proposal 1.
• Placement agent fees of 7.0% of gross proceeds and up to $50,000 in expenses were incurred for the offering.

Risks

• Failure to obtain stockholder approval for the issuance of shares exceeding 19.99% to Alumni Capital LP, which is crucial for unlocking additional funding.
• Inability to raise additional capital in the very near-term, leading to insufficient funds for operating expenses and capital expenditures for the next twelve months.
• Potential for significant delays, reductions, or elimination of development efforts and product-related activities.
• Negative impact on revenue opportunities due to curtailed operations or development.
• Risk of having to reduce marketing efforts, cease operations entirely, or seek protection under the United States Bankruptcy Code.
• Substantial additional costs and expenses associated with holding multiple stockholder meetings if initial approval is not secured.
• Dilution of existing stockholders' ownership and potential decline or increased volatility in stock price upon the exercise of warrants.
• Alumni Capital LP has the right to participate in subsequent financings up to 25% until February 26, 2027.

Future Outlook

The company's future outlook is critically dependent on securing additional capital. Existing cash and equivalents are insufficient to fund operations for the next twelve months. Approval of Proposal 1 is essential to unlock an additional $1.5 million in gross proceeds, which is vital for the company to pursue business growth objectives and avoid severe operational curtailment, including potential delays in development efforts, reduction in marketing, or even cessation of operations and bankruptcy.

Management Comments

• "You are cordially invited to attend a Special Meeting of Stockholders... Whether or not you attend the Special Meeting via the Internet, and regardless of the number of shares of Azitra that you own, it is important that your shares be represented and voted at the Special Meeting."
• "On behalf of the Board of Directors of Azitra, we thank you for your participation."
• "The Board has determined that the Purchase Agreement is advisable and in the best interests of the Company and its stockholders because it provides the Company with a reliable source of capital from an institutional investor familiar with the Company at a relatively lower cost compared to other sources."
• "THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE APPROVAL OF THE ISSUANCE OF MORE THAN 19.99% OF OUR ISSUED AND OUTSTANDING SHARES OF COMMON STOCK, COMPRISED OF SHARES OF COMMON STOCK UNDERLYING WARRANTS, PURSUANT TO THE SECURITIES PURCHASE AGREEMENT WITH ALUMNI CAPITAL LP, DATED NOVEMBER 24, 2025."
• "OUR BOARD RECOMMENDS A VOTE FOR THE APPROVAL OF AN ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES IN FAVOR OF PROPOSAL 1."

Industry Context

This announcement reflects a common challenge for companies, particularly those in development-heavy sectors, to secure ongoing funding for operations and growth. The need for stockholder approval for significant share issuances is a standard corporate governance requirement for publicly traded companies to maintain compliance with exchange listing rules, such as those of NYSE American. The reliance on institutional investors for private placements is a typical financing strategy when public market conditions or company specifics make other forms of capital raising less attractive or feasible.

Comparison to Industry Standards

• The requirement for stockholder approval for issuing more than 19.99% of outstanding common stock at a price less than book or market value (NYSE American Company Guide Section 713(a)) is a standard governance benchmark for listed companies, aimed at protecting existing shareholders from excessive dilution without their consent.
• The consideration of a 'change of control' at 20% or more ownership (NYSE American Company Guide Section 713(b)) is also a common threshold in corporate governance across various exchanges, although specific definitions can vary.
• The use of warrants as part of a private placement offering is a common financing tool, particularly for companies seeking to raise capital while offering investors additional upside potential, similar to structures seen in early-stage or growth companies across biotech, tech, and other sectors.

Corporate Governance

Stakeholder Impact

• **Shareholders**: Face potential significant dilution if warrants are exercised; risk of substantial loss of investment or bankruptcy if the capital raise is not fully secured; opportunity for the company to continue operations and pursue growth if funding is obtained.
• **Employees**: Job security is at risk if the company is forced to curtail or cease operations due to insufficient funding.
• **Customers/Suppliers**: Potential disruption to product development, availability, and business relationships if the company's operations are severely impacted by financial distress.
• **Creditors**: Increased credit risk if the company's financial condition deteriorates further due to a failure to secure necessary capital.

Next Steps

• Stockholders are urged to vote on Proposal 1 (Stock Issuance Proposal) and Proposal 2 (Adjournment Proposal) at the Special Meeting on February 6, 2026.
• The company will publish preliminary voting results at the Special Meeting and file final results in a Current Report on Form 8-K within four business days after the meeting.
• If Proposal 1 is not approved, the company is contractually obligated to call additional stockholder meetings every four months until approval is obtained or the warrants are no longer outstanding.
• If Proposal 1 is approved, Alumni Capital LP will have the option to exercise its warrants for cash in full, providing the company with an additional $1.5 million in gross proceeds.

Key Dates

Recommendation

The company is in a critical financial position, explicitly stating that existing cash is insufficient for the next twelve months and warning of potential bankruptcy if the proposed capital raise is not fully realized. For existing shareholders, the recommendation is to 'hold' pending the outcome of the Special Meeting. A 'yes' vote on Proposal 1 is presented as essential for the company's immediate survival and ability to pursue its business plan, offering a lifeline. A 'no' vote would likely lead to severe financial distress and potential cessation of operations. Investors should carefully consider the high risk associated with the company's current liquidity challenges and the critical importance of this vote for its continued viability.

Keywords

Azitra, AZTR, SEC filing, proxy statement, special meeting, stockholder approval, capital raise, warrants, common stock, NYSE American, Alumni Capital LP, dilution, financing, corporate governance, liquidity